The mission of IPHA is to create a favourable economic, regulatory and political environment, which will enable the research-based pharmaceutical industry in Ireland to meet the growing healthcare needs and expectations of patients.
It aims also to develop an appreciation of the value of medicines, in particular innovative medicines, to healthcare and society as a whole thereby ensuring patients' continued, timely access to the full range of available medicines, regardless of their ability to pay.
These objectives are set in the knowledge that we are on the verge of a new era of personalised and tailored medicine that holds great promise for patients and the healthcare system.
IPHA through its two divisions contributes to public debate and policy in a wide range of areas such as regulation, access, pricing, health promotion and transparency.
We also contribute to public policy debates on a wide rang of issues through our publications and submissions.